Does GLASDEGIB Cause Decreased appetite? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Decreased appetite have been filed in association with GLASDEGIB (Daurismo). This represents 1.5% of all adverse event reports for GLASDEGIB.
8
Reports of Decreased appetite with GLASDEGIB
1.5%
of all GLASDEGIB reports
1
Deaths
4
Hospitalizations
How Dangerous Is Decreased appetite From GLASDEGIB?
Of the 8 reports, 1 (12.5%) resulted in death, 4 (50.0%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for GLASDEGIB.
What Other Side Effects Does GLASDEGIB Cause?
Death (102)
Febrile neutropenia (86)
Pneumonia (50)
Off label use (29)
Neoplasm progression (28)
Neutropenia (26)
Electrocardiogram qt prolonged (18)
Sepsis (18)
Pyrexia (17)
Septic shock (16)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which GLASDEGIB Alternatives Have Lower Decreased appetite Risk?
GLASDEGIB vs GLATIRAMER
GLASDEGIB vs GLECAPREVIR\PIBRENTASVIR
GLASDEGIB vs GLEEVEC
GLASDEGIB vs GLICLAZIDE
GLASDEGIB vs GLIMEPIRIDE